Pharmalittle: AbbVie to lift $2B cap on deals as Humira rivals appear; India to spend $80M to bolster regulatory system
India will spend $79.6 million on strengthening its drug regulatory system after the WHO raised concerns about domestically produced cough syrups being linked children’s deaths.